From 2013 to 2023, the turnover of Biotechnology Research and Experimental Development in Spain has shown impressive growth, increasing from 211.3 million Euros to 1140.0 million Euros. This period witnessed a Compound Annual Growth Rate (CAGR) of 16.57%, with notable year-on-year variations, particularly jumps of 32.38% in 2015 and 29.2% in 2019. Despite some fluctuations, the overall trend highlights a robust increase in industry value.
Specifically, the year-on-year variation in 2023 stood at 11.01%, down from previous years, yet still indicating a healthy upward trajectory. Projections from 2024 to 2028 suggest a slower, yet consistent growth rate with a forecasted 5-year CAGR of 6.26%, leading to a turnover of 1700.0 million Euros by 2028.
Future trends to watch include:
- Technological advancements accelerating research productivity.
- Increased government and private sector investments.
- Emerging biotech startups contributing to industry diversification.
- Potential regulatory changes affecting market dynamics.
- Growth in personalized medicine and genomics sectors.
